Related references
Note: Only part of the references are listed.Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells
Alexandre Rouette et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation
Naduparambil K. Jacob et al.
ONCOTARGETS AND THERAPY (2012)
Hydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanism
Sudjit Luanpitpong et al.
APOPTOSIS (2011)
Chemotherapy in epithelial ovarian cancer
Sandro Pignata et al.
CANCER LETTERS (2011)
Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
Pablo E. Vivas-Mejia et al.
CLINICAL CANCER RESEARCH (2011)
Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Hong Shen et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Recent Advances in the Therapeutic Perspectives of Nutlin-3
Paola Secchiero et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5
Yan Huang et al.
ENDOCRINE-RELATED CANCER (2011)
Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
Amber Yasmeen et al.
GYNECOLOGIC ONCOLOGY (2011)
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Yuan Yuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma
Jong-Lyel Roh et al.
ORAL ONCOLOGY (2011)
Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme
Ruth Villalonga-Planells et al.
PLOS ONE (2011)
Temporal Dissection of Tumorigenesis in Primary Cancers
Steffen Durinck et al.
CANCER DISCOVERY (2011)
Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin
Tingyan Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Ovarian Cancer
Kathleen R. Cho et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Survivin as a global target of intrinsic tumor suppression networks
Minakshi Guha et al.
CELL CYCLE (2009)
Platinum neurotoxicity pharmacogenetics
Sarah R. McWhinney et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Targeting survivin in cancer therapy
Marzia Pennati et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
Llorenc Coll-Mulet et al.
BLOOD (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2
C Cao et al.
MOLECULAR CANCER THERAPEUTICS (2006)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells
ZH Wang et al.
CANCER BIOLOGY & THERAPY (2005)
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
A Sullivan et al.
ONCOGENE (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo
H Uchida et al.
MOLECULAR THERAPY (2004)
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways
E Eldering et al.
NUCLEIC ACIDS RESEARCH (2003)
Survivin, versatile modulation of cell division and apoptosis in cancer
DC Altieri
ONCOGENE (2003)
Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
P Chène
NATURE REVIEWS CANCER (2003)
Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines
CB Powell et al.
GYNECOLOGIC ONCOLOGY (2003)
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
PA Vasey
BRITISH JOURNAL OF CANCER (2003)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy
JR Kanwar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers
WY Chan et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
